In the multivariate COX regression model, PIK3CA exon 20 mutation was associated with a significant decrease in OS of stage IV CRC patients (HR = 2.72, 95% CIs = 1.47-5.09; p-value =0.012, Table 3). The gene discussed is PIK3CA; the disease is colorectal carcinoma.